Ipca Laboratories Ltd (BOM:524494)
₹ 1556.65 -0.9 (-0.06%) Market Cap: 394.93 Bil Enterprise Value: 400.86 Bil PE Ratio: 68.48 PB Ratio: 6.24 GF Score: 91/100
Back to the Transcripts List

Q3 2024 IPCA Laboratories Ltd Earnings Call Transcript

Feb 15, 2024 / 10:00AM GMT
Release Date Price: ₹1151.3 (-0.35%)

Key Points

Positve
  • Domestic formulation business delivered 11% growth for the quarter.
  • Export generics business in the U.K. and other markets grew by 33%.
  • EBITDA margin improved to 18.55% from 15.77% year-on-year.
  • Material cost to sales ratio improved from 34.86% to 32.21%.
  • Consolidated EBITDA margin increased by 1.12% during the quarter.
Negative
  • Branded formulation business in ROW declined due to shipment issues in CIS and Myanmar.
  • Institutional antimalarial business declined from INR 83 crores to INR 77 crores.
  • API business saw a decline from INR 329 crores to INR 285 crores.
  • Challenges in the branded market due to geopolitical issues and licensing delays.
  • Freight and logistic costs remain a concern despite some moderation.
Operator

Ladies and gentlemen, good day, and welcome to the Ipca Laboratories' Q3 and FY '24 Earnings Conference Call hosted by DAM Capital Advisors Limited. (Operator Instructions) Please note that this conference is being recorded. I now hand the conference over to Mr. Nitin Agarwal. Thank you, and over to you, sir.

Nitin Agarwal
DAM Capital Advisors Limited - Analyst

Thanks, Azhar. Hi. Good afternoon, everyone, and very warm welcome to Ipca Lab's Q3 FY '24 post-results earnings call, hosted by DAM Capital Advisors Private Limited.

On the call today, we have representing Ipca Management, Mr. A.K. Jain, Joint Managing Director; and Mr. Harish Kamath, Company Corporate Counsel. I will hand over the call to Mr. Jain to make open comments, and then we'll open the floor for questions. Please go ahead, sir.

Ajit Jain
IPCA Laboratories Ltd - Chief Financial Officer, Managing Director, Executive Director

Thanks, Nitin, and DAM Capital Advisors for organizing this call. Good afternoon to all participants, and thanks for

Already have an account? Log in
Get the full story
Start 7-Day Free Trial
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot
Research Tools
All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board
Product
Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文
Education
Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation
Company
About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program
Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey
Follow Us
download GuruFocus on Apple store download GuruFocus on Google Play
Disclaimers
GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.
© 2004-2024 GuruFocus.com, LLC. All Rights Reserved.